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ApoptosisMembers of the mitochondrial carrier family interact with cardiolipin (CL) as evident from a variety of
functional and structural effects. CL stabilises carrier proteins on isolation with detergents, with the Pi carrier
as the prime example. CL is required for transport in reconstituted vesicles, prime examples are the Pi- and
ADP/ATP carrier (AAC). CL binds to the AAC in a graded manner; 6 CL/AAC dimer bind tightly as measured on
the 31P NMR time scale. 2 additional CL/dimer bind reversibly and a fast exchanging envelope of
phospholipids includes CL as measured on the ESR time scale. In the crystal structure of the CAT–AAC
complex 3 CL bind to the periphery of the AAC in a three-fold pseudo-symmetry. The binding of CL is
implicated to contribute lowering the high transition energy barriers in the AAC. Para-functions of the AAC,
as in the mitochondrial pore transition (MPT) and in cell death are linked to the CL binding of the AAC. Ca++
or oxidants can sequester or destroy AAC bound CL, rendering AAC labile, allowing pore formation and
degradation. Thus AAC, by being vital for energy transfer, constitutes an Achilles heel in the eukaryotic cell.
AAC together with CL is also engaged in respiratory supercomplexes. Different from AAC the similarly
structured uncoupling protein (UCP1) has no tightly bound CL, but CL addition lowers afﬁnity of the
inhibitory nucleotide binding that may contribute to the physiological regulation of the uncoupling activity
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The inner membrane of mitochondria contains a family of carriers
(MCF) that catalyses the passage of solutes between the intramem-
brane and matrix spaces [1,2]. The transport of these solutes is
involved in metabolism, and in maintaining adequate levels of
nucleotides, coenzymes and metal in the matrix space. Thus the
carriers facilitate the metabolic interaction of mitochondria with the
cytosol and the supply of cofactors in the biogenesis of mitochondria
[3–5]. Given the prokaryotic origin of mitochondria the carriers can be
viewed as to allow the symbiosis of the mitochondria with the host
eukaryotic cell. In this perspective carrier functions have evolved to
bridge between both spaces the disparate thermodynamic environ-
ments [6] that are deﬁned by the redox potential of the NAD/NADH
system and by the phosphorylation potential of the ATP/ADP/Pi
system [7].
Based on genomic analysis, in S. cerevisiae 45 and in H. sapiens 43
genes code for proteins with sequence patterns characteristic for the
MCF, such as 6 segments qualifying for transmembrane helices. The
sequence is segmented in 3 similar domains each containing 2 THM,
all arranged in a pseudo three-fold symmetry (for review see [8]. The
atomic structure of the paradigm MCF member, the ADP/ATP carrier
(AAC) from bovine heart (see review [9]) was recently resolved [10],
essentially substantiating the three-fold symmetry with six helices
surrounding a broad funnel. For stabilisation in these crystals the AAC
is complexed with carboxyatractyloside (CAT), imposing an “abortive”
c-state inwhich the binding center is opened to the cytosolic side. This
structure, being the only one available for the MCF, has served as a
template for modelling the structure of other carriers and to identify
the putative substrate binding sites [11,12]. It also formed the basis for
molecular dynamic studies in which electrostatic steering was shown
[13,14,15] to be the major factor for capturing the substrate in the
binding site of the AAC.
Because the AAC is equipped with exceptional features to cope
with its central role in metabolism, such as high expression levels,
highly speciﬁc inhibitors, aimed against different translocation states,
it was a paradigm for elucidating a carrier mechanism in general [9],
and for resolving the structural elements, by starting with the ﬁrst
sequence then exploring the folding and ﬁnally the atomic structure.
Most important in the present context is that the AAC excels in
unusually strong interaction with cardiolipin (CL) [16]. Although it
may be not surprising that mitochondrial carriers interact with CL,
being a major lipid component of the inner mitochondrial membrane,
it is the wide range and variety of interactions found with these
carriers that raise special interest and will be reviewed here. First the
more general protective effects of CL on the mitochondrial carrier
proteins will be reviewed and this will be followed by reporting the
more selective effects of CL on transport activity, and on secondary
carrier functions.
2. Protective effects of cardiolipin on isolated mitochondrial
carriers
On solubilisation of mitochondrial carriers, detergents replace to a
large extent the membrane lipids. Without their native environment
the carriers become labile and the supplementation of phospholipids
especially of CL may protect and facilitate the puriﬁcation of the
carrier in a functionally intact state. The stabilisation of the carrier
proteins is also the reason that CL addition increases the bypass
fraction of hydroxylapatite thus improving the yield and the purity.
The ﬁnal criterion for the beneﬁcial effect was increased transport
activity as measured in the reconstituted proteoliposomes. The most
detailed research on the stabilisation and activation by CL of
mitochondrial carrier was performed with the phosphate carrier
(PiC). Although there was general agreement on the positive role of
CL, variant results were reported as to the preponderance of thesethree effects. Despite some discrepancies, it is clear that all the effects
reﬂect interaction of CL with and the carrier proteins and that there
may be a hierarchy of strong and speciﬁc and of weaker less speciﬁc
interactions, as will be discussed below.
2.1. The phosphate carrier
As ﬁrst reported for the phosphate carrier (PiC), addition of CL
during the solubilisation and isolation by Triton X100/114 greatly
improved the transport activity after reconstitution [17,18]. The
protective effect of CL was most pronounced at higher (N3%) Triton
concentration whereas Triton alone largely inactivates the PiC. If CL
was included in the extracts, a high transport activity was obtained on
reconstitution into vesicles, obviously by restituting CL that had been
removed by the high detergent concentration. It was ﬁrst thought [18]
that the inactivation is irreversible since CL added at a later stage to
the lipids for the reconstitution of the proteoliposomes did not
activate transport. In subsequent work a reversibility of PiC inactiva-
tion by detergent was found [19] by showing that CL could reactivate
the PiC also when added after the solubilisation to the Triton extracts,
but again not, when CL is integrated with the liposome forming lipids.
At variance, in other work CL addition was claimed to increase the
yield of PiC extracted [20] from mitochondria rather than to protect
the PiC. The yield increase by CL addition to the detergent extract was
found to be at the stage of the hydroxyapatite (HTP) column, where CL
greatly promoted the amount of PiC protein eluted [21]. Without CL
added, the eluted fraction from the HTP column contained little PiC
and on subsequent addition of CL, the major amount of PiC was eluted
[21]. These results showed that without CL the PiC in the Triton X 100
extract adsorbs to the HTP and that CL by binding to the PiC maintains
or reverts the protein into a non-adsorbing conformation. There was a
general agreement that these effects on stabilisation and puriﬁcation
yield were highly speciﬁc for CL and could not be achieved with other
anionic lipids. Both results, the reactivation of soluble PiC [19] and the
desorption from HTP by CL [21] can be viewed as demonstrating the
reversibility of the PiC inactivation by these detergents. Why in the
reactivation work [19] without CL the PiC is not adsorbed at HTP at
variance to the desorption results [21] is not clear. Different types of
HTP, and/or the detergent and salt concentrations are probable
factors. The purity of the PiC, i.e. the relative proportion of the PiC to
other proteins in the eluted fraction could be improved by CL addition
under conditions where other co-eluting membrane proteins with
similar size, such as porin and AAC, were retained or retarded on the
HTP [21].
An ambivalent problem is the increase of the PiC transport activity
by CL. In the ﬁrst work with reconstituted liposomes an activation of
transport by CL was shown [17,18]. Subsequently the same group
showed that the PiC cannot be reactivated, when CL is added at a later
stage to the liposome lipids [19]. From this work it became clear that
for activation CL has to be applied to the solubilised carrier and thus
dispersed in the detergent micelles. It seems that endogenous CL
together with PiC can be carried over from the soluble state into the
liposomes. When PiC is solubilised at lower detergent concentration,
apparently endogenous CL still sustains a moderate transport activity
which can further bemaximised by CL addition [19]. At high detergent
concentration, when PiC is nearly inactive, activity depends entirely
on CL addition. The amount of CL required for full activity increases
with the detergent present. Also for desorbing PiC from HTP sufﬁcient
CL must be added to the detergent buffer to reconstitute a fully active
PiC [21].
By showing that CL addition strongly enhanced the amount of
extracted PiC protein [20] it was concluded that the increase of
transport activity by CL was due to an increase of the amount PiC and
not due to an increase of the speciﬁc transport activity. This seemed to
be supported by experiments in which various proportions of acidic
phospholipids such as phosphatidic acid (PA) and CL are incorporated
2050 M. Klingenberg / Biochimica et Biophysica Acta 1788 (2009) 2048–2058into liposomes [22]. Maximum transport rates were observed with
about 8% PA and replacement of PA by CL strongly decreased the rate.
These results agree with the previous reports [19] that unless CL is
admixed to the soluble PiC it will be inactive. In contrast PA seems not
to have this requirement. In other work a clear dependence of
reconstituted PiC transport on CL incorporated into liposomes was
reported [23,24]. Further CL, dispersed without detergent, on
incubation of up to 3 h with proteoliposomes was able to fully
activate transport. Antibiotics adriamycin, doxorubicin, B-daunomy-
cin, that form adducts with CL, abolished reversibly the activation by
CL. The different response to CLmay be partially explained by the prior
exposure in these experiments of the PiC to CL added during the
extraction. Thus PiC is in a pre-active or reversibly inactivated state,
whereas PiC extracted without CL seems in an irreversibly inactive
state unable to respond to the CL included in the liposomes.
In conclusion apparently there may exist two levels of interaction
of CL with PiC: A ﬁrst stage binding that is highly speciﬁc for CL and
maintains the carrier in a “ready” state. A second stage less speciﬁc
binding, where CL can be replaced by other anionic phospholipids, and
that brings the carrier into the active state. This attempt of unifying
the seemingly contradictory results has to await further evidence and
would be supported by analogy to the direct molecular evidence of a
two stage interaction of CL with the AAC, reviewed below.
2.2. Carboxylate carriers
The stabilisation of detergent solubilised carriers by CL has been
observed with several other members of the MCF and used for the
isolation of functionally “intact” carriers from mitochondria (see
review [4]). Featuring similar molecular weights and structures their
separation and puriﬁcation were a challenge in which CL played a
major role. The judicious ﬁne tuning of CL addition combined with
variations of the conditions of how the extracts were passed through
HTP and celite columns enabled the puriﬁcation of these carriers. The
isolation of the tricarboxylate carrier from liver mitochondria proﬁted
early from the CL interference [25] but it took some time to elucidate
the intricacies for separating the tricarboxylate carrier [26]. Isolation
of the dicarboxylate carrier from liver mitochondria also involved the
use of CL for increasing the yield [27,28–30]. Similarly, the carrier for
oxoglutarate isolated from heart [31] and from liver mitochondria [29]
depended on the addition of CL for their isolation.
3. ADP/ATP carrier
3.1. Activation by CL
The AAC affords at least two “technical” advantages over the other
mitochondrial carriers for a more incisive investigation of the carrier
— CL interaction at the molecular level: the high content in
mitochondria and thus the availability of sizable amounts of puriﬁed
AAC protein, and the strong stabilisation of the structure by the
inhibitor ligand carboxyatractyloside (CAT) thus preventing protein
unfolding and degradation [32,33]. No stabilisation by added CL was
necessary for the isolation of the bovine heart CAT–AAC complex.
However, little was done to explore the stabilisation of the
unliganded AAC by CL, since most of the AAC reconstitution work
was performed [34–36] before the use of CL to stabilise the carriers. In
the ﬁrst exploration of the conditions for reconstituting transport of
isolated and puriﬁed AAC, that represented also the ﬁrst reconstitu-
tion of any puriﬁed carrier, variations of the lipid composition played
an important role [36,37]. Egg yolk PC turned out to be the basic
“mortar” for tight vesicles, much superior to the previously used
asolectin in reconstitution with undeﬁned membrane protein
preparations. The ADP–ATP exchange transport was stimulated by
acidic phospholipids [37,38] with the efﬁciency sequence of CL N PS N
PA. CL was the most effective but not exclusive activator among theacidic lipids. Transport was also possible without acidic lipids, when
PE was present in high proportion, although in mitochondria the
content of PE is low [37]. Surprisingly, cholesterol that is mostly
absent from the inner membrane of mitochondria, was also an
effective stimulant [39]. Notably, the activation of the reconstituted
AAC was side speciﬁc as shown by changing the surface potential
and determining the orientation of the AAC in the proteoliposomes
[40].
On reconstituting a mutant of the yAAC2 (C73S) from S. cerevisiae,
an absolute and highly speciﬁc dependence on CL was noted [41]. wt-
yAAC2 did not require any CL admixed to the liposomes whereas
C73S-yAAC2was completely inactivewithout CL. Other acidic PL could
not replace CL, only monolyso-CL activated transport to 12% of the rate
with CL. Parallel 31P NMR measurements of the isolated AAC
preparations revealed that the content of tightly bound CL, as
measured by the difference of the Cl signal strength before and after
SDS addition (see also chapter 3.2), is strongly decreased in the
mutant C73S-y AAC2 as compared to wt-yAAC2 (2.2 versus 6.4 mol
CL/mol AAC dimer). Obviously in C73S-yAAC2 the content of tightly
bound CL has reached a level on isolation or in the mitochondria
below the threshold for sustaining transport activity. In another case,
starting with recombinant AAC from Neurospora crassa expressed in
inclusion bodies in E. coli the threshold requirement for CL is clearly
demonstrated [42]. In this case, the ncAAC isolated from inclusion
bodies does not carry any endogenous CL. On reconstitution an
absolute dependence on CL is observedwith a sigmoid dependence on
the CL content. Only above a threshold of 4% CL, transport becomes
strongly activated reaching a maximum around 10%.
3.2. Binding of CL to AAC
The AAC–CAT complex of bovine bAAC1 as isolated ﬁrst by using
Triton X100 [32,43]. Hydrodynamic and chromatographic analysis
showed [44], that the AAC-Triton X100 micelle consisted of 150 mol
Triton X100/mol dimer AAC and 16 mol PL-phosphate/mol dimer.
Most surprising was the ﬁnding of tightly bound CL in the isolated AAC
based on 31P NMR measurements of the PL composition were
performed parallel to a chromatographic analysis [16]. In the
unfractionated AAC preparation, 31P signals characteristic for PE and
PC were found with the noted absence for CL. In contrast, by
chromatography of the lipid extracts the composition of PC/PE/CL
was measured to be similar to the bulk lipid of the inner membrane,
with CL amounting to 20% of the total PL. After separating the protein
containing micelles from the “free” micelles by sucrose density
centrifugation, PE and PC were largely found to be associated with
the ﬂoating “free” micelle fraction, whereas CL was conﬁned to the
AAC fraction. By 31P NMR in the freemicelles distinct signals for PE and
PC were measured [16] with narrow bandwidth indicating a high
ﬂexibility. In the protein micelles, only after increasing sensitivity 6
times, comparative size 31P NMR signals became visible, correspond-
ing to traces of “mobile” PE and PC and, in a broad band,
corresponding to CL. Themobility of CL calculated from the bandwidth
of about 30 Hz corresponds to the tumbling time of the AAC micelle,
indicating immobility of the CL within the micelle.
The tight binding of CL is further revealed by the response of the
31P signals to SDS addition, as shown in Fig. 1. Even after 4 days
exposure to SDS no “sharp” CL signal appears. Only on heating the
sample a narrow band 31P signal is observed, reﬂecting the release of
CL. By “titrating” the AAC-3H-CAT preparation with increasing
amounts of SDS, 3H-CAT was found to be released earlier than CL
from the AAC, indicating a higher sensibility of the binding sites for
CAT than those for CL to the SDS induced structure change. The
absence of CL from the “free” micelles indicates that most of the CL is
contained in the protein fractions removed by HTP and sepharose gel
chromatography, suggesting that most of the CL is protein bound. The
AAC can be estimated to bind tightly 10% and loosely another 4% of the
Fig. 1. Release of tightly bound CL from bovine heart AAC by SDS and increased
temperature. 31P NMR scan (2000 transients). (A) Solubilised and puriﬁed AAC in Triton
X 100. (B) On addition of 1% SDS after 4 days at 4 °C. (C) After additional heating for 30 s.
From [16].
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reason for the requirement of high salt concentrations for solubilising
mitochondria [33,43].Fig. 2. Ribbon diagram of the bovine AAC1–CAT complex. The binding of 3 CL molecules at the
in the membrane plane. C. View from the m-side. From [59].The amount of CL binding as evaluated from the 31P signal of the CL
released by SDSwas 6mol CL bound/AAC dimer [16]. Thus the amount
of CL bound to the AAC exceeded by far that reported to other
mitochondrial components (see review [45]). The unusual binding
strength was further corroborated by showing [46] that 14C-CL did not
exchange with the endogenous bound CL on an hour scale. Hydro-
genation of the bound CL did not loosen the binding as shown by 31P
NMR [46], indicating that a speciﬁc acyl chain is not required.
The high binding of CL can be rationalised in view of the large
excess of 18 positive charges in the AAC [47,48]. A collar of lysines has
been suggested to face the lipid bilayer at the height of the membrane
surface [49]. In conjunction with Ca++ induced pore openings of the
AAC (see Chapter 4.1) it was proposed [50] that the CLmolecules were
bound at the “collar” lysines such that their headgroups face the
matrix side. The high resolution 2.2 Å crystal structure of the bovine
heart AAC–CATcomplex strikingly conﬁrmed the speciﬁc binding of CL
to the protein [10,51]. In the ﬁrst crystal structure 2 CL bound/
monomer AAC [10] and in a second crystal structure 3 CL bound/
monomer were clearly discerned [51] (Fig. 2). In agreement with the
predictions the phosphate groups of all CL are directed to the matrix
side.
On the basis of 31P NMR line broadening, only very low dissociation
rates corresponding to tight binding can be determined. A much
shorter time scale is covered by ESRmeasurements using spin labelled
(SL)-phospholipids thus permitting a more differentiating evaluation
of binding strength of PL to the AAC [52]. By titrating the solubilised
AACwith SL–CL, a binding of 2molecules CL/dimer AACwas found. SL-
phosphatidic acid (PA) bound with nearly same afﬁnity, whereas the
neutral SL–PC and SL–PE bound only weakly. The importance of ionic
forces is revealed by the sensitivity of this binding to increased salt
concentration. Cleavage by phospholipase A2 and reduction of the spin
label byascorbate suggested that SL–CL is bound at the outer perimeter
of the protein [52]. Lipid binding employing SL–PL was also studied on
AAC reincorporated into PL-membranes [53]. The on- and off-rates in
the exchange of the SL–PL with the ﬁrst shell lipids were determined.
All the acidic SL–PL including SL–CL had similar slow off rates of about
5×106 s−1. The number ofmolecules in the ﬁrst shell was estimated at
50 PL/AAC dimer, pointing out a larger protein — lipid surface than
calculated for a rotational ellipsoid, possibly reﬂecting a “rough”periphery of the protein (CDL 800, 801, 802) is shown. A. View from the c-side. B. View
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addition to the tightly bound non-exchangeable CL.
3.3. The AAC in CL deﬁcient mutant cells
The importance of CL for the AAC was further elucidated in crd1
cells from S. cerevisiae that are deﬁcient in the CL synthase, containing
mitochondria lacking in CL [54]. On non-fermentable source the CL
deﬁcient cells grew slowly and are temperature sensitive. The cells
produced large amounts of the acidic phosphatidyl glyceride (PG)
which apparently could partially replace CL needed by the various
mitochondrial components such as AAC, cytochrome oxidase, cyto-
chrome c reductase etc. In isolated mitochondria the rate of oxidative
phosphorylation was reduced in the mutant to 1/4 of that of wt. It
remained fully sensitive to the inhibitors of the AAC, BKA and CAT.
Surprisingly the amount of yAAC2 in the mutant mitochondria as
measured by 3H CAT binding was the same as in wt. Also the
immunoblots indicate the same level of yAAC2 in the CL deﬁcient
mitochondria. Interestingly, in blue native gels the wt yAAC2 dimer
was shown to migrate slower than the CL deﬁcient AAC dimer,
probably mirroring the lack of the tightly bound 6 CL molecules.
On reconstitution of the isolated yAAC2, the ADP–ADP exchange
required more CL to be added to the phospholipids with yAAC2 from
themutant than from thewt cells [54]. Exchange activity was virtually
zero with yAAC2 originating from the CL deﬁcient yeast. The
stimulation by CL reached about half of the rate of the wt. Apparently
on isolation of the yAAC2 from the CL deﬁcient cells, insufﬁcient
endogenous PG was carried over into the reconstitution.
3.4. CL and structure/function relations in AAC
CL binding is visualised to contribute to the electrostatic network
that is geared to propagate the high interaction energies of ADP3− and
ATP4− binding into the large conformation changes during the
translocation. With ATP4− and ADP3−, the AAC transports large and
highly charged solutes requiring large rearrangements within the
carrier structure. According to the “induced transition ﬁt” (ITF) [55,56]
the high activation energy barriers of large conﬁguration changes
must be compensated by the interaction energies between substrate
and protein reached in the transition state. These requirements are
satisﬁed in the AAC by a high share of electrostatic interactions
between substrate and AAC on the one side and within the protein on
the other side. The extraordinarily high and tight binding of 3 CL/AAC
monomer may play a role in matching the large interaction energies.
The additional ionic bonds could markedly increase the interaction
energy for facilitating the necessary large rearrangements in the
transition between the c- and m-states. In the AAC–CL3 complex the
additional 6 negative charges are more than balanced by the high
amount of 18 uncompensated basic residues/AAC monomer [47]. In
comparison, UCP1, which lacks tight binding of CL, has an excess of
only 9 basic residues [57]. Correspondingly, the substrates, H+ or fatty
acid anions are small and carry only one charge. In the AAC the excess
of positive charges is distributed such that more charges are at the
matrix than at the cytosolic half (11:7). Simulating the structure of the
other MCF members from the AAC structure, also in most other
carriers the positive charge excess is larger in the matrix than in the
cystosol half (personal communication, F. Palmieri, C.L. Pierri). All this
argues for a preferential or exclusive binding of CL to the mitochon-
drial carriers at the matrix side.
Binding of CL was originally envisaged to involve a “collar” of
lysines at the matrix side [49,50]. The crystal structure vindicated the
tight binding of 3 CL/monomer, and provides a detailed picture of CL
interactions with the AAC [10,51]. As shown in Fig. 2 in each of the 3
repeat domains one CL binds to the uneven numbered kinked
transmembrane helices (TMH). The acyl chains are close to aromatic
residues that surround the intrahelical prolines responsible for thekinks. During the translocation, going from the c-state to the m-state,
the cavity initially opened to the c-side has to be closed by the c-gate
and the m-gate becomes open [58]. This process is envisaged to
involve pivoting of the uneven numbered TMH around the prolines,
such that them-section of the helix is turned outside and the c-section
inside [59]. Concomitantly the even numbered TMH are twisted [60].
These conﬁguration changes might translate via the aromatic groups
into position changes of the adjacent CL acyl chains. In particular the
phosphate headgroups may contribute to the opening of the gates on
the transitions between the c- and m-states. According to the crystal
structure the CL phosphates are linked to basic residues near the N-
terminal of the small matrix helices. On transition to them-state these
ion bonds may be loosened and shifted to form new ion bonds with
basic residues near the C-terminal side of the matrix helices in case
they are now geometrically favoured. In this context it is noteworthy,
that according to 31P NMR measurements CL binds also tightly to
isolated AAC brought into the m-state by binding BKA (K. Beyer
unpublished), although the AAC seems to have a less rigid structure
according several criteria [9].
The preferred binding also of added CL to the matrix side was
demonstrated by probing the access to C56 in the isolated AAC–ATR
complex of bovine bAAC1 with pyrene maleimide (PYM) [61]. ADP
stimulated the access to C56 [62,63] and addition of CL, but not of
other PL, inhibited the reaction of PYM. Even when AAC was ﬁxed in
the m-state by BKA, CL addition prevented the access of PYM.
Treatment of the micelles with phospholipase A2 facilitated the
reaction of PYM, rendering it less ADP dependent. Addition of CL
restored the ADP dependency, but higher amounts of CL prevented
again PYM access. The results were interpreted to reﬂect a direct
blockage of the C56 by excess CL. Support for this notion comes from
the crystal structurewhere CL binds to nearby K51 and per vdW forces
to I53 and I54 [59].
In the second published crystal structure dimers of the AAC can be
discerned in the crystal lattice [51]. Interestingly, two CL were
localised at the interface of two adjacent AAC monomers involved in
linking the monomers within a dimer. The phosphate groups are
connected to the matrix short helices and lysines C267 and K51 of the
opposing monomers. Thus, with the hydrophobic forces of the alkyl
chains CL seems to provide the glue for the dimer formation. It was
proposed [59] that the two CL are also involved in the cross talk for the
cooperative function of the monomers.
4. Para-functions of AAC–cardiolipin interaction
4.1. The mitochondrial pore transition (MPT)
Apart from the 1:1 exchange of ADP and ATP, the AAC can mediate
an efﬂux of nucleotides from isolated mitochondria that is induced to
varying stages by ions and prooxidants (see reviews [9,64,65]). Ca++
ions are the most prominent inducers of this permeabilisation of the
inner mitochondrial membrane which has been classiﬁed as the
“mitochondrial pore transition” (MPT). The criteria for involvement of
the AAC were the inhibition of the MPT by ADP and by BKA and a
stabilisation by CAT and atractyloside (ATR), indicating that the MPT
requires the c-state of the AAC. Further support for a role of AAC in
MPT came from the inhibition by SH-reagents known to stabilise the
m-state [66] and by crosslinking reagents, known to stabilise the c-
state [67,68]. In patch clamp studies with reconstituted AAC [50,69]
large single channels (800 pS) were opened by Ca++. The channels
were sustained by CAT but closed by ADP and BKA, similarly to the
MPT, suggesting the involvement of AAC possibly as a central
component in a larger MPT complex. As a mechanism it has been
proposed that Ca++ taken up in thematrix sequesters the headgroups
of the CL bound to the AAC, as illustrated in Fig. 3. [50]. Based on the
high afﬁnity of Ca++ for complexing CL [70,71], Ca++ is suggested to
displace CL from the AAC, exposing the positive charges at the matrix
Fig. 3. Scheme for interpreting the Ca++ induced pore opening of the AAC and the involvement of the tightly bound CL. Ca++ taken up into the matrix forms complexes with bound
CL, releasing lysine groups at the matrix “ collar”. The displacement of CL and the release of the positive charges at the AAC destabilise the AAC and open the m-gate in addition to
the open c-gate, thus forming a pore. From [50].
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structure partially by electrostatic repulsion and open the m-gate so
that an open channel through AAC is formed. However by deleting all
AAC isoforms in murine liver, evidence has been presented, that the
AAC is not an obligatory element of the MPT [72]. Ca++ inducible and
cyclosporine A sensitive MTP was retained in the mutant mitochon-
dria, delegating the AAC to a more accessory inducer role in the MPT
[73]. It was also debated [74] that AAC forms the default pore in MPT
and that in the mutant mitochondria another mitochondrial carrier
may have replaced the AAC. A related proposal is that the pore in the
MPT is formed by misfolded carrier proteins including the AAC [75].
Prooxidants are shown to enhance the sensitivity of the MPT to
Ca++ [65,67]. In the patch clamp system the prooxidant butyl
peroxide promoted pore opening by inhibiting the voltage gating,
probably by oxidising the SH groups involved in gating [76,77]. This is
consistent with the role of SH groups and the enhancing effect of
prooxidants described in detail for the MPT [67,68,78,79]. Prooxidants
and oxygen radicals may also affect the CL surrounding the AAC
because of the exceptionally high degree of unsaturation of the acyl
groups [46] that renders CL most vulnerable to ROS attack. Thus on
treating mitochondria with Ca++ and butylperoxide, [80–82] in SDS
gels the protein band corresponding to the AAC was found to be
shifted upward corresponding to a higher mass. It was the only
clearly detectable mass increase among the mitochondrial proteins.
Mostly lysines of the AAC were shown to be modiﬁed by Schiff base
adducts of malondialdehyde and hexenal, produced from the
oxidation of PL lipid chains. AAC was the favoured target because
the aggressive aldehydes formed by the oxidants from the tightly
bound CL could in situ attack the AAC. In addition the high lysine
content predestined the AAC to be highly responsive to aggressive
oxidant products. Notably this modiﬁcation of AAC was dependent on
the transport state: CAT inhibited and BKA allowed the modiﬁcation,
indicating that the m-state is required in which the AAC is known to
be more vulnerable to trypsin [33,83].
4.2. CL and AAC in apoptosis
Multiple studies point to a role of the MPT in the early stages of the
apoptotic or necrotic pathways of cell death [84–86]. Through theMPT,
AAC andCLparticipate in triggering apoptosis, as indicated for example
by the inhibition of apoptosis by the AAC inhibitor BKA that also
functions as a MPT blocker [87]. However, it is still debated, whether
and to what extent theMPTcan be bypassed in the Bcl-2/BAX induced
apoptosis [88]. Within the conﬁnes of this review on CL and carriers, it
is not possible to expand on these extensively discussed questions but
instead to concentrate on the role of CL and AAC in apoptosis.
Out of the apoptotic signalling proteins tBid, a 15 kDa protein
generated from Bid, that is a member of the Bcl-2 family, has emerged
as a key player in understanding the mechanism of mitochondria and
the role of CL therein. tBid was shown (see review [89]) to enhancethe permeabilisation of the outer membrane by BAX by promoting the
pore forming oligomerisation of BAX and thus the release of
cytochrome c, a key factor in triggering the apoptotic cascade.
However, in model liposomes tBid was shown [90] not to bind to
outer membrane lipids but to liposomes resembling the contact sites
between outer and inner membranes that are rich in CL. Further,
electron tomography of mitochondria indicated that tBid binds to the
contact sites between outer and inner membranes and there to affect
speciﬁcally CL [91]. The synergistic induction of cytochrome c release
by tBit and BAX also depended on CL, showing that tBid requires CL for
its proapoptotic action.
Concomitantly to cytochrome c release, tBid caused a macroscopic
remodelling of the total inner membrane [92] where the positive
curvature of the external membrane face was strongly increased and
the junction pores between the intracristae to the intermembrane
space are enlarged thus facilitating cytochrome c efﬂux. Sine CL is
mainly on the matrix leaﬂet, it is a dilemma how tBid can interact
unless it reaches the matrix by membrane instabilities at the contact
sites. Bax was shown to promote transbilayer diffusion of CL [93] and
thus tBid in synergismwith Bax can contact CL. The negative curvature
of the m-side would be consistent with tBid interactions in the model
systems. These tBid effects on the membrane structure are reminis-
cent to membrane structure changes observed in heart mitochondria
involving the AAC, as evidenced by the response to ADP [94] and to
inhibitors of the AAC [95–97]. The transition from a contracted state
with ATR, where the matrix surrounds the vacuolar intermembrane
space, to a decontracted state with ADP and BKA, where the matrix
formed vesicle type interstitium indicated enlargement of one
membrane leaﬂet relative to the other. It was suggested [97] to be
caused by a surface charge excess at the expanding surface that may
be caused by the redistribution of anionic lipids concomitant to the
transition of the AAC between the c- andm-states. The high content of
AAC in heart mitochondria may dictate these overall re-conﬁgurations
of the inner membrane. In electron-tomographic analysis the inner
membrane changes induced by the AAC ligands were suggested [98]
to be driven by the redistribution of CL, similarly as in the tBid driven
changes.
In liposomes containing Ca++ and CL the relation of membrane
curvature to tBid induced leakage was studied [99]. On enhancing the
negative curvature by addition of PE (CL:PC:PE=1:1:1) the tBid
induced leakage is markedly increased whereas in liposomes without
curvature obtained by replacing CL with PG, tBid was unable to induce
leakage. 31P NMR measurements showed that conversely tBid
interaction promotes negative membrane curvature thus destabilising
the lipid bilayer and inducing leakage pores [99]. Hereby tBid induces
a partial hexagonal lipid phase.
Anothermore general role of CL in tBid triggered apoptosis emerges
from comparing mitochondria from wt and CL deﬁcient cdrl yeast
strains [100,101]. The inhibition ofmitochondrial ATP synthesis by tBid
was shown to result from the inhibition of the ADP/ATP transport
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ATR. In cdrlmitochondria the reduced ATP synthesis could not further
be inhibited by tBid, indicating that in wt mitochondria, by
redistributing CL, tBid may have caused a deﬁciency of CL at the AAC.
cdrl mitochondria are also resistant to the membrane degradation
through oxidation and hydrolysis of CL that is induced by tBid in wt
mitochondria that thus impairing oxidative phosphorylation [102].
The CL deﬁcient system also contributed to unravel the complex
interplay of tBid and CL with BAX in the release of cytochrome c. BAX
had been shown to induce apoptosis in the cdrl strain without the
need for CL and tBid [103] challenging the role of CL. This was
conﬁrmed, but speciﬁed [104] to require high expression levels of BAX
in the CL deﬁcient cells. At low BAX levels Cyt c release required CL (wt
strain) and tBid expression. It was concluded (104) that tBid primarily
binds CL and the consequent effects on the membrane and its
components promote the BAX oligomer formation. The transient
induction of the MPT by tBid was suggested to result from a
concomitant inelasticity of the membrane caused by binding CL.
4.3. CL and AAC in basal uncoupling
Basal uncoupling of mitochondria sustains parts of the basal
metabolism prevailing in rest. The mechanism of the H+ “leakage” to
sustain this uncoupling is unclear. Part of this uncoupling is assumed
to be caused by fatty acid cycling through the AAC as shown by the
sensitivity to CAT. There exist also a large CAT insensitive and fatty acid
independent portion that nevertheless seems to be associated with
the AAC since it is related to the ATP expression level, as shown be
ablating or overexpressing the AAC [105]. It might be speculated, that
the high acyl chain unsaturation of the CL bound to the AAC facilitates
a slow H+ translocation through the membrane.
4.4. The AAC–CL couple as an Achilles heel
These “parafunctions” of the AAC, whether physiological, patholo-
gical or artefacts, are all consequences of its primary function that is
furnishingATP from themitochondria to the cytosol. Aswas elaborated
above, the unusually large virtual energy barriers of the ADP/ATP
transport and the concomitant strong rearrangements are linked to the
many ionic charges in the AAC protein and are further enhanced by
electrostatic CL binding. These are matched by the high intrinsic
binding energies of ADP3− and ATP4− in the transition state. However,
these well balanced elements for an efﬁcient ADP/ATP exchange
render the AAC captive to changes in the membrane background, in
particular because of the surrounding CL. They range from the more
subtle redistribution of CL by tBid, the drastic withdrawal by Ca++, to
the destruction of surrounding CL by oxidants ampliﬁed by the high
degree of unsaturation of the CL acyl chains and the resulting
irreversible alkylation of SH and lysine groups. Thus the AAC faces a
barrage of derangements that the cell may have adopted as a useful
service in theMPT linked apoptosis, but that at an advanced stage leads
to necrotic death. With the AAC and its interdependence to CL, the
eukaryotic cell has acquired an “Achilles heel” sensitive to commonly
occurring damaging factors, such as Ca++ and oxygen radicals.
5. AAC, CL and supercomplexes
With blue native electrophoresis the existence of supercomplexes
composed of the respiratory complexes III and IV were shown [106].
Further, using CL deﬁcient yeast strains or by titrating CL with
doxycyclin [107–109] a vital role of CL for the association of the
complexes was demonstrated. Recently, with a new dual afﬁnity tag
AAC was found to participate in these supercomplexes [110],
composed of one AAC dimer and two copies each of complex III and
IV. Additional supercomplexes between AAC and other mitochondrial
carriers were tentatively identiﬁed. In CL deﬁcient mitochondria fromcdr1 strain these complexes are absent or less deﬁned. Possibly CL acts
as a glue between these protein complexes by intercalating between
the transmembrane sections of the components, similarly as shown in
the crystal structure of (AAC)2 where 2 CL bind between the AAC
monomers [51]. The (AAC)2 seems to be predestined for the anchoring
role by providing the high amount of 6 tightly bound CL/dimer, out of
which 4 CL may serve to connect the AAC with other proteins. The
great density of AAC in the inner membrane (bovine heart 1.4, S.
cerevisiae 0.45 (AAC)2/mg protein) amounts to a molar ratio (AAC)2/
complex IV=1.9.(S.c) to 2.5 (b.H.) [111,112]. Thus there is about twice
as much (AAC)2 as could be recruited by the supercomplex.
It was suggested [110] that in this supercomplex the electro-
phoretic ATP export proﬁts from the adjacent H+ pumps generating a
localised strong electrochemical gradient. Previously CL has been
proposed [113] to function with the phosphate headgroups as a
localised H+ buffer thus restricting H+ from the bulk domain.
Adjacent to the respiratory H+ pumps the buffering by CL would
increase the voltage component Δψ of the electrochemical gradient
within the supercomplex. Thus besides connecting proteins, CL could
locally guarantee a high Δψ that is needed to drive the directional ATP
export versus ADP import through the AAC.
Notably, no supercomplex between AAC and ATP synthase is
invoked in this recent report [110], although previously the existence
of a supercomplex consisting of ATP synthase, AAC and PiC (a
“synthasome”) isolated from liver mitochondria was described [114].
Intuitively its existence might enhance the efﬁciency of newly
synthesised ATP export by avoiding mixing with the matrix ATP and
ADP pool. ATP would be directly received by the AAC from the
adjacent synthase. However no data on the stoichiometric composi-
tion of these detergent released fractions are given. Further, against
earlier evidence [115,116], a micro-compartmentation of ATP synthesis
and transport had been previously postulated [117,118] on the basis of
various experimental studies (see review in [9]). However, by
overcoming the former experimental problems, evidence was pro-
vided arguing against a localised cooperation of ATP synthesis and ATP
[9,119].
6. Uncoupling protein
Uncoupling proteins (UCP) form a subfamily in MCF consisting of
up to ﬁve members in mammalians [120,121]. UCP1, occurring
exclusively in brown adipose tissue, is the best studied member. It
catalyses H+ transfer through the inner membrane converting the
electrochemical gradient generated by electron transport into heat.
The H+ translocation is dependent on free fatty acids. But the
mechanism of the H+ transfer is still a matter of controversy [122–
124]. Essentially twomodels are discussed, UCP directly transports H+
[125] or UCP transports fatty acid anions and the free fatty acids
return through the lipid bilayer thus indirectly catalysing H+
transport [124]. The H+ transport is inhibited by the purine
nucleotides ADP, ATP, GDP, and GTP. The binding of these nucleotides
and the concomitant inhibition are strongly pH dependent relieving
binding with increasing pH.
On reconstituting isolated UCP1 a high H+ transport activity was
measured [126,127] in proteoliposomes with only egg yolk PC as lipid
component. Addition of acidic PL such as PS decreased the activity. CL
addition at N10% also decreased activity. A striking effect of CL was
observed at the inhibition of the H+ transport by nucleotides (G.
Basset andM. Klingenberg, unpublished), as demonstrated in Fig. 4. CL
strongly attenuates binding of GTP and the inhibition of H+ transport.
Thus in a typical setting at pH 6.85, the KD for 14C-GTP is increased 10
fold from 1.39 to 13.7 μM by 12% CL. This effect of CL may have great
signiﬁcance for the regulation of the uncoupling activity of UCP. The
cytosolic concentration of the physiologically dominant regulator free
(not complexed with Mg++) ATP seems too high to permit UCP1 to
assume the active state. The concentration of free ATP ranges at 100 to
Fig. 4. The effect of CL on the nucleotide binding and inhibition of UCP1. UCP1 isolated from hamster brown adipose tissue is reconstituted in egg yolk PC vesicles, with or without 8%
cardiolipin. Incubation at pH 6.7 under conditions as described in [125]. (A) Measurements of 14C-GTP binding. (B) Inhibition of H+ transport activity by GTP. Parallel experiment to A.
The H+ transport is activated by 100 μM oleate (G. Basset, M. Klingenberg, unpublished).
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the strong pH dependency of ΔpKD/ΔpH≈−1.8 [128] a shift of pH to
7.5 would increase the KD to 8 μM, which is still insufﬁcient to relieve
the ATP inhibition. A cytosolic pH increase up to 8.0 was noted on
activation of thermogenesis in brown adipose tissue [129]. Since CL
increases the KD about 10 fold, the KD could reach 80 μM at pH 7.5 and
thus largely liberate UCP1 from ATP. With these ﬁndings, the
conclusion (cf [130–132]) that nucleotides do not play a role in
intracellular regulation of UCP1 because of a too high afﬁnity, seems to
be unfounded. Thus with the binding afﬁnity decrease caused by CL,
the strongwell documented pH dependence of the nucleotide binding
in UCP1 [133–135], gains additional signiﬁcance as a major physio-
logical regulator of uncoupling activity. These results may also at least
partially explain the discrepancies reported on the GDP sensitivity of
reconstituted UCPs where vesicles with and without CL have been
employed [136,137].
UCP1 has been ﬁrst isolated from brown adipose tissue following
procedures only slightly modiﬁed from the isolation of AAC
[44,138,139]. In both cases the isolated protein formed a dimer in
the detergent (e.g. Triton X100) micelle. According to 31P NMR spectra
the adherent PL had proportions of PC/PE/CL=45/48/19 Mol/UCP1
dimer, similar to that in the mitochondrial inner membrane (K. Beyer,
M. Klingenberg, unpublished). On addition of SDS the increase of the
CL signal, amounting to only 0.6 mol/mol dimer, was within the
measuring error. Thus, in contrast to AAC, isolated UCP1 does not
contain tightly bound CL, but is highly responsive to CL addition as
evident in the regulation of UCP1 by nucleotides. The binding of
nucleotides to UCP1 has two stages, ﬁrst a loose binding without
inhibition of H+ transport and second a tight binding leading to
inhibition [140,141]. Fluorophore (DAN-, DANSYL-) derivatives of
ATP or GTP signal binding to UCP1 by their strong ﬂuorescence
increase, but H+ transport was not inhibited. Only adenine- and
guanine-, di- and tri-phospho nucleotides drive UCP1into the
subsequent inhibited state by changing the structure into a more
tightened form as shown by increasing resistance to trypsin [140].
The transition from the initial binding to the second stage is notably
slow [123]. In this setting CL seems to shift the distribution between
the loose and tight binding state of UCP1 in such as manner that
on decrease of nucleotide concentration the active state of UCP1
becomes favoured.7. Conclusions
Mitochondrial solute carriers constitute a major part of the inner
membrane proteins. Facing membrane lipids consisting of up to 20%
CL, it is not surprising that the carriers have developed a symbiosis
with CL. The carriers are speciﬁcally qualiﬁed for binding CL by their
net positive charge excess that reaches a maximum in the AAC, where
the tightly bound CL may have a cofactor role for facilitating transport
by providing additional electrostatic energy. A wide range of effects
are produced by this interaction, from activating transport, stabilising
the protein and modulating inhibitor binding. Withdrawal of CL from
the AAC by Ca++, tBid or by oxidation of CL deranges the AAC,
promoting apoptotic or necrotic cell death. All this is based on binding
of CL, ranging from a tight speciﬁc cofactor type binding in the AAC,
additional speciﬁc binding, to the participation of CL in the surround-
ing lipid annulus. The dependence of the carriers, in particular of AAC,
on CL imposes an Achilles heel on the eukaryotic cell.
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